How Much Upside is Left in Castle Biosciences (CSTL)? Wall Street Analysts Think 50.08%

Castle Biosciences, Inc. (CSTL) closed the last trading session at $23.74, gaining 4.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $35.63 indicates a 50.1% upside potential.The average comprises eight short-term price targets ranging from a low of $30.00 to a high of $41.00, with a standard deviation of $3.54. While the lowest estimate indicates an increase of 26.4% from the c ...